Vaxart, Inc.

Contributing Author

Recent Articles by Vaxart, Inc.

Jun-13	Vaxart Announces Preliminary Results of Annual Meeting of Stockholders VXRT GlobeNewswire
Jun-11	Vaxart Reports Positive Clinical Data Demonstrating that its Second-Generation Vaccine Technology Produces Much Stronger Antibody Responses than its First-Generation Technology VXRT GlobeNewswire
Jun-10	Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial VXRT GlobeNewswire
Jun-02	Vaxart Announces Adjournment of Annual Meeting of Stockholders VXRT GlobeNewswire
May-29	Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025 VXRT GlobeNewswire
May-29	Vaxart's Founder and Chief Scientific Officer Provides Video Update to Stockholders VXRT GlobeNewswire
May-28	Vaxart Answers Additional Frequently Asked Questions from Retail Investors VXRT GlobeNewswire
May-27	Vaxart Initiates Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial VXRT GlobeNewswire
May-21	Vaxart Announces Adjournment of Annual Meeting of Stockholders VXRT GlobeNewswire
May-20	Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) VXRT GlobeNewswire
May-16	Vaxart Approves Resolutions to Narrow Proposed Reverse Split Range and Proposes Reducing Authorized Shares at Future Stockholder Meeting VXRT GlobeNewswire
May-15	Vaxart Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial VXRT GlobeNewswire
May-14	Vaxart Publishes Positive, Complete Data from a Phase 2b Challenge Study of its First-Generation Oral Pill Norovirus Vaccine Candidate in Science Translational Medicine VXRT GlobeNewswire
May-13	Vaxart Provides Business Update and Reports First Quarter 2025 Financial Results VXRT GlobeNewswire
May-13	Vaxart Appoints Jeroen Grasman as Chief Financial Officer VXRT GlobeNewswire
May-12	Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement VXRT GlobeNewswire
May-05	Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress VXRT GlobeNewswire
May-02	Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13 VXRT GlobeNewswire